PTPN2 and Leukopenia in Individuals With Normal TPMT and NUDT15 Metabolizer Status Taking Azathioprine
ABSTRACT Leukopenia is a common dose‐dependent side effect of azathioprine, often leading to drug discontinuation. Variants in TPMT and NUDT15 are associated with azathioprine‐induced leukopenia but only explain 25% of cases. Thus, we aimed to identify novel genetic risk factors among TPMT and NUDT1...
Saved in:
| Main Authors: | Laura L. Daniel, Puran Nepal, Jacy Zanussi, Alyson L. Dickson, Peter Straub, Tyne W. Miller‐Fleming, Wei‐Qi Wei, Adriana M. Hung, Nancy J. Cox, Vivian K. Kawai, Jonathan D. Mosley, Charles Michael Stein, QiPing Feng, Ge Liu, Ran Tao, Cecilia P. Chung |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-06-01
|
| Series: | Clinical and Translational Science |
| Subjects: | |
| Online Access: | https://doi.org/10.1111/cts.70220 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pilot Study of Valganciclovir-Induced Leukopenia in Kidney Transplant Recipients With NUDT15 Genetic Variation
by: Madan M. Bahadur, et al.
Published: (2024-10-01) -
Long-term safety of azathioprine for treatment of neuromyelitis optica spectrum disorders
by: Ana Beatriz Ayroza Galvão Ribeiro GOMES, et al.
Published: (2021-03-01) -
Case Report: Polymyxin E-associated reversible leukopenia
by: Suxin Wan, et al.
Published: (2025-08-01) -
Comparative efficacy of moxibustion in chemotherapy-induced leukopenia: A Bayesian network meta-analysis
by: Zun-Yuan Li, et al.
Published: (2025-06-01) -
Alopecia as the first manifestation of azathioprine myelosuppression in a genetically predisposed patient
by: Debashish Mishra, et al.
Published: (2019-01-01)